INTRODUCTION
Previous studies have shown that human platelets incorporate radioactive phosphate into phospholipids both in vivo and in vitro (1) (2) (3) (4) (5) . In the in vitro studies, phosphatidic acid and phosphatidylinositol were labeled more rapidly than other phosphatides, suggesting that these compounds were synthesized rapidly and that they might be responsible for some important metabolic function. For example, the incorporation of radioactive phosphate into phosphatidic acid and phosphatidylinositol is stimulated in certain cell types performing active transport or secretion, and it has been postulated that these phosphatides are linked intimately to this process (6) (7) (8) (9) .
A preliminary report of this work has been published in abstract form, 1969. J. Clin. Invest. 48: 13a. subsequent procedures were carried out at 4VC using plastic or siliconized glass materials. The platelets were sedimented by centrifuging at 2000 g for 20 min. They were resuspended and washed twice with 0.15 M NaCl containing 10' M disodium ethylenediaminetetraacetate (Na2EDTA) and 102 M 2-mercaptoethanol, buffered with 0.05 M Tris-maleate pH 6.5 (subsequently referred to as buffered 0.15 M NaCl).
The platelet button was resuspended to an estimated concentration of 1.5 X 109 platelets/ml in 0.25 M sucrose containing 10' M Na2EDTA and 10'2 M 2-mercaptoethanol adjusted to a final pH of 7.0 with NaOH (subsequently referred to as buffered 0.25 M sucrose). The suspension was routinely frozen (solid C02) and thawed six times, and used as the enzyme source.
Preparation of platelet subcellular fraction-s. Washed platelet pellets were suspended in 0.44 M sucrose containing 10' M Na2EDTA and 10' M 2-mercaptoethanol buffered with 0.02 M Tris-HCl pH 7.0, and were homogenized according to the technique outlined by Marcus, ZuckerFranklin, Safier, and Ullman (19) . Granule and membrane fractions were prepared on continuous 30-60% sucrose gradients. Platelet homogenates were also fractionated by sequential centrifugation at 1000 g for 20 min, 12 ,000 g for 12 min, and 100,000 g for 60 min. All pellets were washed once and then suspended in buffered 0.25 M sucrose. All platelet fractions were assayed immediately or within 24 hr if stored at -20'C.
Preparation of erythrocyte membranes. Erythrocytes were separated from heparinized whole blood using siliconized glass-bead columns (20 (21) . The washed pellets were suspended in buffered 0.25 M sucrose. The protein concentration was adjusted to 4 mg/ml, and the suspensions were frozen at -20°C until assayed.
Separation of leukocytes. Lymphocytes and polymorphonuclear (PMN) leukocytes were separated by methods minimizing platelet contamination in an effort to assess their contribution to the enzyme activity of the frozen and thawed platelet preparations (22, 23) . To prepare lymphocytes, heparinized whole blood was layered on Ficoll gradients and subjected to isopycnic centrifugation (22) . The lymphocytes in the supernate were then sedimented by ratezonal centrifugation in a discontinuous sucrose gradient. The pellet contained 2-5 erythrocytes and 24 platelets/100 lymphocytes. No other type of leukocytes were detected on stain smears. PMN leukocytes were separated from heparinized whole blood by isopycnic centrifugation in discontinuous gradients of colloidal silica-polyvinylpyrrolidone (23) . The PMN leukocyte band was washed six times with buffered 0.15 M saline. The final pellet contained 2-30 erythrocytes and 24 platelets/100 leukocytes. No mononuclear cells were detected. The leukocyte preparations were adjusted to 5 X 107/ml, and the suspension was frozen and thawed six times. Specimens were frozen at -20°C until assayed.
Chemical analysis. Lipid phosphorus, esters, and cytidine were determined by established techniques (24) (25) (26) . Nitrogen was measured by perchloric acid digestion of the lipid (27) followed by nesslerization (28) . Lipid choline was quantitated by hydrolysis with barium hydroxide (29) , and precipitation according to the Reineckate method (30) . Calcium was measured by titration with Na2EDTA in the presence of the indicator calcein (31) . Lipids were dissolved in cyclohexane and the degree of oxidation determined by ultraviolet absorption at 235 and 255 my (32) . The quality of aqueous emulsions of lipid was estimated by the degree of light absorption at 420 and 540 mAi using 2-4 mm lipid-buffer emulsions (33) . Protein was determined by the method of Lowry, Rosebrough, Farr, and Randall (34) .
Phosphatidyicholine. Phosphatidylcholine was isolated from hen egg yolks using sequential aluminum oxide and silicic acid column chromatography (35) . Thin-layer chromatography showed one spot (36) , and the phosphorus: choline molar ratio was 1: 1.047. Phosphatidic acid. Phosphatidic acid was prepared from phosphatidylcholine by the method of Davidson and Long using Savoy cabbage as the source of phospholipase D (37) . The reaction was terminated by adding 0.1 volume of cold 1 N HCI. The mixture was filtered through a bed of celite with suction. The ether phase was separated, washed twice with 0.01 M Na2EDTA, and taken to dryness under reduced pressure in an atmosphere of nitrogen. The lipid was resuspended in chloroform and purified by silicic acid column chromatography (38) . The phosphatidic acid eluted with methanol: chloroform (6: 94 v/v) was taken to dryness as before, and the sodium salt prepared (39) . The Tris salt was prepared similarly but it was insoluble in small volumes of ether, so it was suspended in ether and washed with the same organic solvents used to reprecipitate the sodium salt. The phosphatidate salts were dried under reduced pressure and stored at -20'C under nitrogen in a desiccator. These compounds migrated as a single spot on thin-layer chromatography (40) Lysophosphatidic acid. Lysophosphatidic acid was prepared by converting phosphatidylcholine to lysophosphatidylcholine with Crotalus adamanteus venom (42) followed by treatment with Savoy cabbage phospholipase D in the absence of ether. The reaction was stopped with 0.1 volume of 1 N HCO and the lipids extracted with chloroform: methanol (2: 1 v/v). The extract was dried as before and the sodium salt prepared. The salt was dissolved in chloroform and purified by silicic acid column chromatography (43) . The lipid was reprecipitated as the sodium salt and stored at -20'C. The phosphorus: ester ratio was 1.0: 0.99. Thinlayer chromatography showed a trace of phosphatidic acid.
Cytidine diphosphate diglyceride. CDP-diglyceride was prepared as described by Agranoff and Suomi (26), except final separation was initiated by drying the pyridine mixture under reduced pressure in an atmosphere of nitrogen, resuspending the lipid in chloroform, and washing once with cold 10' N HC1. After drying over Na2SO4, the extract was purified by silicic acid column chromatography (13) . The material eluted with methanol: chloroform (1: 1 v/v) was taken to dryness as before, dissolved in ether, emulsified in water, and the ether removed under reduced pressure. The pH was raised to 7.5 with 1 N NH40H and the water removed under reduced pressure. The precipitate was washed twice with ether and stored at -20'C. This compound had a phosphorus: ester: cytidine molar ratio of 2.0:1.85: 0.93 and migrated as one spot on thin-layer chromatography in two systems (26, 36) .
Preparation of lipid emulsions. Sodium phosphatide was dissolved in ether and the appropriate buffer added followed by removal of the ether in a vigorous stream of nitrogen. The Tris phosphatidate was added directly to the buffer followed by shaking. The lipid emulsions were cloudy, and light absorption combined with centrifugation was used to estimate the character of the emulsions (33) . A typical emulsion of 3.87 mm sodium phosphatidate in 0.25 M TrisHCl buffer, pH 7.8 gave OD readings of 0.53 and 0.99 at 540 and 420 mru respectively. After centrifugation at 10,000 g for 30 min, the supernate contained 2.88 mm lipid phosphorus and the OD readings were 0.055 and 0.136.
Enzyme assay. The procedure employed was similar to that by Carter and Kennedy (40) . An assay mixture of 0.5 ml was incubated in a Dubnoff shaker at 370C in 50 ml glassstoppered conical centrifuge tubes. The buffer containing a phosphatidate salt, Na2ATP adjusted to pH 7 with NaOH, and a mixture of Li4CTP-3H and Na2CTP adjusted to pH 7.0 with NaOH (final SA 1 Ci/mole) were combined at 4VC. The platelet suspension in buffered 0.25 M sucrose was added and the tubes mixed. The tubes were placed in the incubator at 370C for 1 min and MgCl9 added with mixing.
At the end of the incubation, 5 ml of 0.1 N HCl in methanol was added followed by 10 ml of chloroform. The organic layer was washed three times with 20 ml of 2 M KCI and a chloroform aliquot dried in a scintillator vial. 15 Identification of product. Platelets disrupted by repeated freezing and thawing (0.5 mg of protein) were incubated for 60 min at 37°C in a reaction mixture identical with that described in Fig. 1 The complete reaction mixture was identical with that detailed in Fig. 1 Enzyme concentration. The enzyme activity was proportional to protein concentration up to 0.75 mg/0.5 ml assay volume in either Tris-HCl or imidazole-HCl. At higher protein concentrations, CDP-diglyceride production continued to increase at a slower rate (Fig. 1) .
pH optimum and effect of buffer salts. The reaction occurred at optimal rates in 0.1 M Tris-HCl (Fig. 2) or 0.1 M triethanolamine-HCl buffer at pH 7.0. These two salts buffered the reaction mixture poorly below pH 7.0, and although smaller amounts of CDP-diglyceride were formed, the results were of uncertain significance and are not illustrated. Increasing the concentration of Tris-HCl to 0.2 and 0.4 mole/liter caused an 18% and 25% decrease in the reaction rate. In imidazoleHCl, the optimal activity occurred at pH 7.0, but the rate was only 80% that achieved in Tris-HCl (Fig. 2) . 0.1 M maleate and 0.1 M phosphate were inhibitory to the reaction when used as buffers alone and with Tris. The pH optima in Tris-maleate (Fig. 2) and Tris-phosphate buffers (not shown) were similar to the pH optimum of imidazole-HCl. Phosphate buffer was inhibitory at a concentration as low as 0.04 mole/liter which resulted in a reaction rate only 24% of that found with Tris-HCI.
Substrates and cofactors. Table I shows the effect of omission of some of the reagents from the complete reaction mixture. 4 mm 2-mercaptoethanol had no effect alone, but in the presence of Na2EDTA is increased activity by about 13%. 6 Na2EDTA increased the reaction rate (Table I ). The optimal concentration of Na&EDTA was 1 mmole/ liter. Concentrations of 5 mmoles/liter or higher caused a complete inhibition of CDP-diglyceride production.
No significant amount of CDP-diglyceride was produced in the absence of added phosphatidic acid (Table  I ). The concentration of phosphatidic acid producing a half-maximal velocity under the conditions shown was 1.4 mmoles/liter (Fig. 3) The conditions of the experiment were identical with those detailed in Fig. 1 except 0 .1 M Tris-HCl buffer, pH 7.0, was used and the reaction mixtures contained 0.6 mg of protein at the temperature indicated.
rates described are related only to the substrate phosphatidic acid. The Km for CTP was 0.16 mmole/liter (Fig. 3) .
Temperature effects. The production of CDP-diglyceride in Tris-HCl buffer pH 7.0 was investigated at different temperatures and the rate of reaction compared with that obtained at 370C (Table II) . Enzyme which was boiled 5 min and assayed at 370C gave values only 1-1.5% of those found with the same enzyme assayed before boiling. Platelets disrupted by repeated freezing and thawing and stored at -20'C lost no activity over 30 days. At 4VC there was a 55% loss of activity in 7 days.
Miscellaneous observations. 0.5 mm pyrophosphate caused a 64% decrease in the reaction rate. 0.016 mM CDP-diglyceride decreased enzyme activity by 25% and 0.116 mmole/liter caused a 60% decrease.
0.04 M KCI, 0.04 M NH4Cl, or 0.1 M NaCl did not change the reaction rate in either Tris-HCl or phosphate buffer. 1 mm KF had no effect on the reaction rate but 4 mm or higher concentrations were inhibitory.
When platelet homogenates were precipitated with acetone or methanol at -200C and resuspended in buffered 0.25 M sucrose, no enzyme activity was present. Attempts to solubilize the enzyme with organic solvents, detergents, and urea were unsuccessful and resulted in enzyme inactivation.
Detergents depressed the reaction rate. CDP-diglyceride production was 28, 0, 23, and 51%o as high as control values, respectively, in the presence of 3.2 mM sodium cholate, 1 mg/ml Cutscum (isooctylphenoxy polyoxyethylene ethanol), 0.5 mg/ml Triton X-100 (octylphenoxy polyethoxyethanol), and 0.1 mg/ml Tween 80 (polyoxyethylene sorbitan monooleate). Enzyme activity in platelet subcellular fractions. Platelets were homogenized and the subcellular components separated as described in Method. Platelet material which sedimented between 1000 and 12,000 g had a specific SA 2.8 times greater than material sedimented at 1000 g. The component sedimented between 12,000 and 100,000 g had a SA 3.9 times greater than the 1000 g sediment. The supernate from the 100,000 g centrifugation was inactive and did not contain inhibitors when mixed with the other fractions. When platelets were sonicated for time intervals less than 10 sec, more enzyme activity and protein remained in the supernate after centrifugation at 2000 g compared with the other methods of platelet disruption. Sonication did not solubilize the enzyme and the use of high energy levels or longer time intervals caused loss of enzyme activity.
When platelet "membranes" and "granules" were separated on sucrose density gradients (19) , the membranes contained four times the activity of the granules.
Enzyme activity in other blood cells. Lymphocytes or PMN leukocytes, disrupted by repeated freezing and thawing, contained an enzyme which catalyzed the conversion of CTP-'H into a chloroform-soluble product. Enzyme activity in the platelets from normal subjects and patients. Platelets from 10 normal subjects disrupted by repeated freezing and thawing (protein concentration 2.2-3.0 mg/ml) catalyzed the production of 261-377 jumoles of CDP diglyceride/mg of protein per min. The values for eight uremic patients (BUN > 100 mg/100 ml) ranged from 255 to 388 A/Amoles/mg of protein per min. Platelets from two patients with polycythemia vera, two patients with Marfan's syndrome, and one patient each with chronic myelogenous leukemia, Glanzmann's thrombasthenia, and homocystinuria gave enzyme activities in the normal range.
Influence of CDP-diglyceride production on the incorporation of inositol into platelet lipids. CDP-diglyceride may be converted to phosphatidylinositol by an enzyme from mammalian tissues, and in order to determine whether this occurred in the platelet system, an experiment was performed to compare the rate of incorporation of inositol-14C and CTP-3H into chloroformsoluble products. Platelets disrupted by repeated freezing and thawing (0.5 mg of protein) were incubated with 4 mm Na phosphatidate, 2 mm inositol-14C (SA 28 mCi/mole), 1 mm CTP-8H (SA 1 Ci/mole), 0.04 M MgCL2, 0.4 mm NaEDTA, 4 mm 2-mercaptoethanol, 0.1 M sucrose, and 0.1 M Tris-HCl buffer in a total volume of 0.5 ml at a final pH of 7.5. The reaction mixtures were incubated for varying time intervals up to 120 min and then extracted and counted as described in Methods. The incorporation of cytidine was 20-40% greater than the incorporation of inositol for the first 60 min. Thereafter, inositol incorporation exceeded the cytidine incorporation by 8-10%. Reaction mixtures from which either CTP or phosphatidic acid was omitted converted no inositol-'4C to a chloroform-soluble product. These results indicate that the synthesis of phosphoinositols in this system was dependent on CDP-diglyceride production.
DISCUSSION
These studies have demonstrated that human platelets have the enzymatic apparatus necessary to convert phosphatidic acid to CDP-diglyceride, a well-established intermediate in the biosynthesis of phosphatidylinositol and phosphatidyl glycerol in mammalian tissues (10) (11) (12) (13) . CDP-diglyceride is also an intermediate in the synthesis of other phospholipids in microorganisms and possibly could fulfill that role in platelets as well, but to data there is no evidence for this in mammalian tissues (14, 15) . The characteristics of the enzyme (CTP: diacyl glycerophosphate-cytidyl transferase) prepared from platelets were similar to those from other mammalian sources (40, 45) . The reaction proceeded optimally if Mg was present in the reaction mixture, although Mn could substitute partially, as has been reported for liver (40) . In embryonic chick brain CDPdiglyceride formation occurred with Mn, and Mg in the presence of Mn inhibited the enzyme (45) . The inhibition of the platelet enzyme by maleate or Tris-maleate buffers is of interest in view of the use of this latter buffer system in studies of the brain enzyme (45) . The activity of the platelet enzyme per milligram of protein was 25-33% that described for liver microsomes and 3-4 times that found in embryonic chick brain mitochondria. The activity was a small fraction (0.2%) of that found with Micrococcus cerificans (46) . Further, it differed from the bacterial and yeast systems in not being activated by univalent cations (46, 47) , and it was inactivated by precipitation with organic solvents at low temperature and by the detergent Cutscum (46) .
The phosphatidic acid used in these experiments was derived from egg phosphatidylcholine and therefore does not necessarily represent the "natural" substrate for the enzyme. The fatty acids of egg phosphatidylcholine are highly unsaturated (48, 49) but contain only 2-5% arachidonic acid. Marcus, Ullman, and Safier (50) have recently reported on the fatty acid composition of platelet phospholipids and approximately 42% of the molecular weight of phosphatidylinositol was composed of arachidonic acid. Phosphatidic acid with arachidonic acid esterified in the beta position may be the preferred substrate for the enzyme.
These studies extend those previously reported in which it was found that 'POL is incorporated rapidly into phosphatidic acid and phosphoinositide in platelets in vitro (1) . (52) have reported that platelets can synthesize phospholipids de novo from labeled a-glycerophosphate. Platelets are known to exchange phospholipids with plasma as well, and the relative contribution of these two sources remains to be evaluated.
The role of the present enzyme system in the platelet is not clear. Phospholipids of platelets are essential reactants in blood coagulation, but must also subserve important functions in the maintenance of the cell. Abnormalities of lipid synthesis might influence any of these functions. In the small group of patients with diseases known to influence platelet function in blood coagulation (53) (54) (55) , the enzyme was present in the platelets in normal quantities. Further work will be necessary to determine the significance of this reaction in the normal or diseased platelet.
